[go: up one dir, main page]

NO933816L - Antiretroviral acyl compounds - Google Patents

Antiretroviral acyl compounds

Info

Publication number
NO933816L
NO933816L NO933816A NO933816A NO933816L NO 933816 L NO933816 L NO 933816L NO 933816 A NO933816 A NO 933816A NO 933816 A NO933816 A NO 933816A NO 933816 L NO933816 L NO 933816L
Authority
NO
Norway
Prior art keywords
antiretroviral
acyl compounds
compounds
acyl
salts
Prior art date
Application number
NO933816A
Other languages
Norwegian (no)
Other versions
NO933816D0 (en
Inventor
Guido Bold
Alexander Fassler
Marc Lang
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO933816D0 publication Critical patent/NO933816D0/en
Publication of NO933816L publication Critical patent/NO933816L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Det er beskrevet forbindelser med formel I hvori R} betyr acyl, og salter derav, som viser antlreovlral virksomhet, spesielt mot AIDS. Det er videre beskrevet fremgangsmåter for fremstilling av forbindelsene.Compounds of formula I wherein R 1 is acyl and its salts are disclosed, showing anti-ultraviolet activity, especially against AIDS. Methods for preparing the compounds are further described.

NO933816A 1992-10-23 1993-10-22 Antiretroviral acyl compounds NO933816L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH331292 1992-10-23

Publications (2)

Publication Number Publication Date
NO933816D0 NO933816D0 (en) 1993-10-22
NO933816L true NO933816L (en) 1994-04-25

Family

ID=4253267

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933816A NO933816L (en) 1992-10-23 1993-10-22 Antiretroviral acyl compounds

Country Status (19)

Country Link
EP (1) EP0594540B1 (en)
JP (1) JPH06228132A (en)
KR (1) KR940009177A (en)
CN (1) CN1089606A (en)
AT (1) ATE164592T1 (en)
AU (1) AU670121B2 (en)
CA (1) CA2108934A1 (en)
CZ (1) CZ223893A3 (en)
DE (1) DE59308336D1 (en)
FI (1) FI934634A7 (en)
HU (1) HU214330B (en)
IL (1) IL107356A (en)
MX (1) MX9306588A (en)
NO (1) NO933816L (en)
NZ (1) NZ250017A (en)
PL (1) PL173529B1 (en)
SK (1) SK115193A3 (en)
TW (1) TW372972B (en)
ZA (1) ZA937859B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878728B1 (en) 1999-06-11 2005-04-12 Vertex Pharmaceutical Incorporated Inhibitors of aspartyl protease
US20040122000A1 (en) 1981-01-07 2004-06-24 Vertex Pharmaceuticals Incorporated. Inhibitors of aspartyl protease
US5888992A (en) 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
MXPA93002392A (en) 1992-03-11 2005-02-04 Narhex Ltd Amine derivatives of oxo- and hydroxy-substitued hydrocarbons.
WO1993018006A1 (en) 1992-03-11 1993-09-16 Narhex Limited Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
DE19500120A1 (en) 1995-01-04 1996-07-11 Bayer Ag New acylated pseudopeptides with trifluoromethyl-substituted 2-azabicyclooctane
DE19500122A1 (en) * 1995-01-04 1996-07-11 Bayer Ag New pseudopeptides with trifluoromethyl-substituted 2-azabicyclooctane
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
ES2235492T3 (en) 1998-06-19 2005-07-01 Vertex Pharmaceuticals Incorporated INHIBITORS OF ASPARTIL PROTEASA SULFONAMIDE TYPE.
US6319946B1 (en) 1999-02-12 2001-11-20 Vertex Pharmaceuticals Incorporated Inhibitors of aspartyl protease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US5024968A (en) * 1988-07-08 1991-06-18 Engelsberg Audrey C Removal of surface contaminants by irradiation from a high-energy source
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
GB8927915D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Novel alcohols

Also Published As

Publication number Publication date
CA2108934A1 (en) 1994-04-24
MX9306588A (en) 1994-05-31
TW372972B (en) 1999-11-01
HUT65876A (en) 1994-07-28
FI934634L (en) 1994-04-24
IL107356A (en) 1998-01-04
PL173529B1 (en) 1998-03-31
FI934634A7 (en) 1994-04-24
JPH06228132A (en) 1994-08-16
ATE164592T1 (en) 1998-04-15
EP0594540B1 (en) 1998-04-01
NO933816D0 (en) 1993-10-22
SK115193A3 (en) 1994-11-09
AU670121B2 (en) 1996-07-04
CN1089606A (en) 1994-07-20
DE59308336D1 (en) 1998-05-07
FI934634A0 (en) 1993-10-20
ZA937859B (en) 1994-04-25
CZ223893A3 (en) 1994-05-18
NZ250017A (en) 1996-04-26
AU4907293A (en) 1994-05-05
KR940009177A (en) 1994-05-20
IL107356A0 (en) 1994-01-25
HU9303011D0 (en) 1994-01-28
EP0594540A1 (en) 1994-04-27
HU214330B (en) 1998-03-02

Similar Documents

Publication Publication Date Title
TR199700844T1 (en) Pyrazolyl-Benzoil T�revleri.
AU565898B2 (en) 1,8-naphthyridine derivatives
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
AR038427A2 (en) COMPOUNDS 15-RENT-14-HYDROXYL OF MARCFORTINA AND PARAHERCUAMIDA
UA7140A1 (en) Method for producing pyridine derivatives
NO933816L (en) Antiretroviral acyl compounds
BG60249B2 (en) Thiazole compound for treatment of ulcers
ATE211732T1 (en) N-BENZYLPIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES
CA2100503A1 (en) Piperidine Derivatives of Benzimidazole
HU9300110D0 (en) Method for producing aryl-cycloalkyl derivatives and medical preparatives containing them as active substance
NO982987L (en) Amidinoproteasehemmere
ATE75743T1 (en) HYDRAZINE DERIVATIVES AND THEIR USE.
NO934196L (en) N, N-disubstituted arylcycloalkylamines, their salts, drugs containing these compounds, their use and process for their preparation
NO933611L (en) ANTI-TUMOR AND ANTI-PSORIATIC AGENTS
JO1704B1 (en) New active compounds
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
NO171412C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-OXATATIOLAN OR 1,3-DITIOLANDER DERIVATIVES
NO864108L (en) PROCEDURE FOR THE PREPARATION OF NEW FLAVON DERIVATIVES.
TR199701362T1 (en) New process for the preparation of ropivacaine hydrochloride monohydrate.
NO890455D0 (en) PROCEDURE FOR THE PREPARATION OF 5-SUBSTITUTED ORNITHIN DERIVATIVES.
NO922151L (en) GINGEROL AND GINGERDIOLD DERIVATIVES AS HYPOCOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS
TW344743B (en) Therapeutic nucleosides
DE3566263D1 (en) NOVEL CYANOIMIDAZOLE NUCLEOSIDE DERIVATIVES
ATE68174T1 (en) 2-AMINOACETAMIDE DERIVATIVES.
DK0713702T3 (en) Anxiolytic agent